VeriMomzinc palmitoyl nonapeptide-14 hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
Pregnancy-safe products containing zinc palmitoyl nonapeptide-14
Related ingredients
Frequently asked questions
- zinc palmitoyl nonapeptide-14 hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
- zinc palmitoyl nonapeptide-14 emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific hazards from SCCS/CIR/ECHA or peer-reviewed literature for this ingredient. Dermal absorption is expected to be negligible for a large, palmitoylated peptide; therefore systemic exposure sufficient to reach breastmilk is not supported by available regulatory sources (no ECHA harmonised hazard, no CIR or SCCS contraindication).
- zinc palmitoyl nonapeptide-14 bebek cildi için güvenli mi?
- No data indicating intrinsic developmental or reproductive hazard in infants. Mechanistic data are absent. Although adult dermal absorption is expected to be negligible, infant skin has higher surface-area-to-weight and an immature barrier; per the scoring guidance, exposure score is increased by +1 relative to adult (from 0 to 1) in the absence of evidence of complete non-absorbability. No infant-specific adverse data were found in the searched regulatory sources.
- VeriMom zinc palmitoyl nonapeptide-14 nasıl puanlıyor?
- VeriMom zinc palmitoyl nonapeptide-14'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte zinc palmitoyl nonapeptide-14 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.